Chapter

Polymer Therapeutics I

Volume 192 of the series Advances in Polymer Science pp 95-134

Date:

PEGylation of Proteins as Tailored Chemistry for Optimized Bioconjugates

  • Gianfranco PasutAffiliated withDepartment of Pharmaceutical Sciences, University of Padua
  • , Francesco M. VeroneseAffiliated withDepartment of Pharmaceutical Sciences, University of Padua Email author 

* Final gross prices may vary according to local VAT.

Get Access

Abstract

The high potential of peptides and proteins as therapeutic agents has not been fully exploited because of their common shortcomings: the only exist for a short lifetime in the body, they degrade easily in vivo and in vitro, and they cause immunological reactions. Among several proposed solutions, PEGylation, the covalent modification using polyethylene-glycol (PEG), has achieved interesting results, leading to a novel series of products that have already reached the market, while others will be available soon. In the past few years this technology, first developed for peptides and proteins, has been applied to non-peptide drugs, opening a new area of investigation that is receiving increasing interest. In this case, PEGylation allows the therapeutic application of molecules with inadequate water solubility, high toxicity, or a poor pharmacokinetic profile. This chapter describes recent achievements in PEGylation of proteins and peptides, with a special emphasis on the chemistry of conjugation, and it reports many examples from literature and from the authors' own experimental results.

https://static-content.springer.com/image/chp%3A10.1007%2F12_022/MediaObjects/ga_APS022.gif
PEG PEGylation PEG-protein PEG-drugs Polymer therapeutics